These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1081925)

  • 1. Cell-mediated immunity in rubella assayed by cytotoxicity of supernatants from rubella virus-stimulated human lymphocyte cultures.
    Vesikari T; Kanra GY; Buimovici-Klein E; Cooper LZ
    Clin Exp Immunol; 1975 Jan; 19(1):33-43. PubMed ID: 1081925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic activity against rubella-infected cells in the supernatants of human lymphocyte cultures stimulated by rubella virus.
    Kanra GY; Vesikari T
    Clin Exp Immunol; 1975 Jan; 19(1):17-32. PubMed ID: 1204239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of circulating and secretory antibody and cell-mediated immunity following immunization.
    Waldman RH; Ganguly R
    Dev Biol Stand; 1975; 28():273-84. PubMed ID: 1126572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief report. In vitro effects of Rubella virus, strain RA 27/3, on human lymphocytes. III. Inhibition of mitogen stimulation transferred by supernatants from virus-infected cultures.
    Maller R; Sörén L
    Acta Pathol Microbiol Scand C; 1978 Apr; 86(2):89-91. PubMed ID: 696334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination.
    Rossier E; Phipps PH; Polley JR; Webb T
    Can Med Assoc J; 1977 Mar; 116(5):481-4. PubMed ID: 837312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I. Evidence that lymphotoxin activity involves both cytotoxic and stimulating factors.
    Ryzewska AG; Darbrowska BK
    Immunology; 1976 Nov; 31(5):677-87. PubMed ID: 136420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired cell-mediated immune response in patients with congenital rubella: correlation with gestational age at time of infection.
    Buimovici-Klein E; Lang PB; Ziring PR; Cooper LZ
    Pediatrics; 1979 Nov; 64(5):620-6. PubMed ID: 386238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon production in lymphocyte cultures after rubella infection in humans.
    Buimovici-Klein E; Weiss KE; Cooper LZ
    J Infect Dis; 1977 Mar; 135(3):380-5. PubMed ID: 850076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the lymphocyte in vitro response to rubella antigen and phytohemagglutinin by a whole blood method.
    Buimovici-Klein E; Vesikari T; Santangelo CF; Cooper LZ
    Arch Virol; 1976; 52(4):323-31. PubMed ID: 1016065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination.
    Jokinen S; Osterlund P; Julkunen I; Davidkin I
    J Infect Dis; 2007 Sep; 196(6):861-7. PubMed ID: 17703416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of lymphotoxin in target cell destruction induced by mitogen-activated human lymphocytes in vitro. II. The correlation of temperature and trypsin-sensitive phases of lymphotoxin-induced and lymphocyte-mediated cytotoxicity.
    Kramer SL; Granger GA
    J Immunol; 1976 Feb; 116(2):562-7. PubMed ID: 1082459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the cell population involved in viral-specific cell-mediated cytotoxicity in man: evidence for T cell specificity.
    Rola-Pleszczynski M; Hurtado RC; Woody JN; Sell KW; Vincent MM; Hensen SA; Bellanti JA
    J Immunol; 1975 Jul; 115(1):239-42. PubMed ID: 50349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired in vitro cell-mediated immunity to rubella virus during pregnancy.
    Thong YH; Steele RW; Vincent MM; Hensen SA; Bellanti JA
    N Engl J Med; 1973 Sep; 289(12):604-6. PubMed ID: 4269242
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte.
    Santoli D; Trinchieri G; Lief FS
    J Immunol; 1978 Aug; 121(2):526-31. PubMed ID: 681748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination.
    Ovsyannikova IG; Jacobson RM; Vierkant RA; Jacobsen SJ; Pankratz VS; Poland GA
    J Infect Dis; 2005 Feb; 191(4):515-9. PubMed ID: 15655774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigations on the dependency of hemagglutination inhibition titers against rubella virus on the number and quality of antibody molecules (author's transl)].
    Hoppe G
    Zentralbl Bakteriol A; 1981; 249(2):143-51. PubMed ID: 7269848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers.
    Terada K; Itoh Y; Wakabayashi T; Teranishi H; Akaike H; Ogita S; Ouchi K
    Vaccine; 2015 Nov; 33(45):6093-8. PubMed ID: 26275479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA and the rubella-specific immune response following vaccination.
    Van Eden W; UytdeHaag F; Loggen HG; Plantinga AD; De Vries RR; Van Rood JJ
    Exp Clin Immunogenet; 1984; 1(2):70-4. PubMed ID: 6400993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of lymphocyte stimulation by measles virus.
    Sullivan JL; Barry DW; Albrecht P; Lucas SJ
    J Immunol; 1975 May; 114(5):1458-61. PubMed ID: 804515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte responses to rubella antigen and phytohemagglutinin after administration of the RA 27/3 strain of live attenuated rubella vaccine.
    Vesikari T; Buimovici-Klein E
    Infect Immun; 1975 Apr; 11(4):748-53. PubMed ID: 1120613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.